Conspecific chemosensory communication controls a broad range of social and sexual behaviors. In most mammals, social chemosignals are predominantly detected by sensory neurons of a specialized olfactory subsystem, the vomeronasal organ (VNO). The behavioral relevance of social chemosignaling puts high demands on the accuracy and dynamic range of the underlying transduction mechanisms. However, the physiological concepts implemented to ensure faithful transmission of social information remain widely unknown. Here, we show that sensory neurons in the basal layer of the mouse VNO dynamically control their input-output relationship by activitydependent regulation of K ϩ channel gene expression. Using large-scale expression profiling, immunochemistry, and electrophysiology, we provide molecular and functional evidence for a role of ether-à-go-go-related gene (ERG) K ϩ channels as key determinants of cellular excitability. Our findings indicate that an increase in ERG channel expression extends the dynamic range of the stimulus-response function in basal vomeronasal sensory neurons. This novel mechanism of homeostatic plasticity in the periphery of the accessory olfactory system is ideally suited to adjust VNO neurons to a target output range in a layer-specific and use-dependent manner.
Introduction
Mammals have evolved a number of distinct olfactory subsystems (Firestein, 2001; Zufall and Munger, 2001; Ache and Young, 2005; Breer et al., 2006) . Among those, the accessory olfactory system and its peripheral sensory structure, the vomeronasal organ (VNO), play a critical role in detecting semiochemicals that control conspecific social behavior (Halpern and Martinez-Marcos, 2003) . In rodents, apical vomeronasal sensory neurons (VSNs) express members of the V1R receptor family, whereas VSNs of the basal layer express V2R receptors (Mombaerts, 2004; Rodriguez, 2004) . These receptors are thought to detect pheromonal cues that show immense structural diversity ranging from small volatile molecules (Restrepo et al., 2006) and sulfated steroids (Nodari et al., 2008) to complex peptides (Leinders-Zufall et al., 2004; Kimoto et al., 2005) and proteins (Chamero et al., 2007) .
Semiochemicals trigger profound changes in endocrine status and initiate genetically preprogrammed behaviors (Brennan and Zufall, 2006) . To ensure faithful transduction of such biologically relevant information, the dynamic range of VSN input-output relationships needs to be constantly adjusted within meaningful firing rate limits. Neurons achieve such homeostatic plasticity by balancing ionic conductances via compensatory feedback in an activity-dependent manner (Turrigiano, 1999; West et al., 2001; Zhang and Linden, 2003) . In this context, modulation of K ϩ channel expression represents a key molecular mechanism to regulate neuronal input-output relationships (Zhang and Linden, 2003) .
The ether-à-go-go-related gene (ERG) channels represent a unique K ϩ channel subfamily that exhibits distinct gating and pharmacological properties (Schwarz and Bauer, 2004) . In mice, the ERG subfamily is composed of three members [mERG1-3 (Warmke and Ganetzky, 1994; Shi et al., 1997) ] with two splice variants of mERG1 [mERG1a and mERG1b (Lees-Miller et al., 1997; London et al., 1997) ]. So far, most studies have focused on hERG, the human homolog of mERG1, which is a key mediator of cardiac action potential (AP) repolarization. Inherited hERG mutations cause long QT syndrome 2, a lethal arrhythmic disorder Sanguinetti et al., 1995; Nerbonne and Kass, 2005) . In neurons, however, the physiological roles of ERG channels are poorly understood (Sanguinetti and TristaniFirouzi, 2006) . Overlapping subunit expression in central neuron somata (Guasti et al., 2005) suggests that endogenous ERG channels form heterotetramers, likely coassembling with promiscuous ␤-subunits such as MinK-related peptides (MiRPs). A characteristic feature of ERG channels is their unconventional gating. Activated during depolarization, fast inactivation and a combi-nation of fast recovery from inactivation and relatively slow deactivation during repolarization underlie inward net ion movement (Schwarz and Bauer, 2004) . However, gating properties vary substantially between endogenous and heterologously expressed ERG channels and between subunits (Pond and Nerbonne, 2001; Hirdes et al., 2005) . So far, neuronal ERG currents have been described in cerebellar Purkinje neurons (Sacco et al., 2003) and ventral horn interneurons (Furlan et al., 2007) .
Here, we analyzed activity-dependent K ϩ channel expression in the mouse VNO. Compared with stimulus-deprived animals, ERG1 channel expression is upregulated in mice chronically exposed to pheromonal cues. We show that basal neurons coexpress ERG1 and ERG3 and exhibit a fast ERG-mediated K ϩ current that is significantly reduced after stimulus deprivation. We demonstrate a function of ERG-mediated currents in VSN spike repolarization and show impaired AP firing after ERG channel inhibition. Together, our findings support a concept of homeostatic plasticity in the accessory olfactory system based on usedependent regulation of ERG channel expression. This mechanism is ideally suited to adjust a target vomeronasal output range in a layer-specific manner.
Materials and Methods
Solutions and chemicals. For tissue preparation and electrophysiological recordings, the following solutions were used: (1) HEPES-buffered extracellular solution (S 1 ) containing (in mM) 145 NaCl, 5 KCl, 1 CaCl 2 , 1 MgCl 2 , 10 HEPES, pH 7.3 (adjusted with NaOH), osmolarity of 300 mOsm (adjusted with glucose); (2) bicarbonate-buffered oxygenated (95% O 2 /5% CO 2 ) extracellular solution (S 2 ) containing (in mM) 120 NaCl, 25 NaHCO 3 , 5 KCl, 1 MgSO 4 , 1 CaCl 2 , 5 BES ( N, N-bis[2-hydroxyethyl]-2-aminoethansulfonic acid), pH 7.3, osmolarity of 300 mOsm; (3) elevated potassium extracellular solution (S 3 ) containing (in mM) 110 NaCl, 40 KCl, 1 MgCl 2 , 1.5 CaCl 2 , 5 EGTA (110 nM free Ca 2ϩ ), 10 HEPES, tetrodotoxin (TTX; 0.5 M), pH 7.3, osmolarity of 300 mOsm; (4) low Ca 2ϩ solution (S 4 ) for enzymatic tissue digestion containing (in mM) 135 NaCl, 5 EGTA, 4.25 CaCl 2 , 5 KCl, 10 NaOH, 1 MgCl 2 , 10 HEPES, pH 7.3, osmolarity of 300 mOsm; and (5) HEPESbuffered pipette solution containing (in mM) 143 KCl, 10 HEPES, 2 KOH, 0.3 CaCl 2 , 1 EGTA (110 nM free Ca 2ϩ ), 1 MgATP, 0.5 NaGTP, pH 7.1 (adjusted with KOH), osmolarity of 290 mOsm. If not stated otherwise, all chemicals were purchased from Sigma. Free Ca 2ϩ concentrations were calculated using WEBMAXC STANDARD (available at www.stanford.edu/ϳcpatton/maxc.html).
To ensure full, rapid isolation of ERG channel-mediated potassium currents in voltage-clamp recordings, saturating concentrations of the methanesulfonanilide drug E-4031 (10 M) or the recombinant peptide rErgtoxin-1 (100 nM; Alomone Labs) were applied in S 3 . Subunit-specific mERG1 currents were isolated using the recombinant peptide rBeKm-1 at a concentration (100 nM; Alomone Labs) that completely blocks mERG1 without affecting mERG3 (Restano-Cassulini et al., 2006) .
Animals. All animal procedures were in compliance with the European Union legislation on the protection of animals used for experimental purposes (Directive 86/609/EEC) and with recommendations put forward by the Federation of European Laboratory Animal Science Associations. Mice used for experiments shown in Figures 2-6a-f and supplemental Figures 1a-d, 2, 3a-d, and 4 (available at www.jneurosci.org as supplemental material), either wild-type C57BL/6 mice or gene-targeted mice in which all mature VSNs can be visualized based on homozygous expression of green fluorescent protein (GFP) under the control of the regulatory sequences of the olfactory marker protein (omp) gene (OMP-GFP) (Potter et al., 2001) , were housed in groups of both sexes at room temperature on a 12 h light/dark cycle with food and water available ad libitum. If not stated otherwise, experiments used young adults of either sex. We did not observe any obvious differences between males and females in neither electrophysiological recordings nor molecular or immunochemical experiments.
VNO preparation. Mice were killed by CO 2 asphyxiation and decapitation using sharp surgical scissors, following the "guidelines for euthanasia of rodents using CO 2 " recently issued by the National Institutes of Health Office of Laboratory Animal Welfare. The VNO was dissected in oxygenated, ice-cold S 1 as described previously (Leinders-Zufall et al., 2000; Spehr et al., 2006) . For preparations of acute slices, the intact VNO was embedded in 4% low-gelling-temperature agarose, and coronal slices (300 m) were cut on a Vibratome (VT1000S; Leica Microsystems). Slices were transferred to a submerged (S 2 ), chilled, and oxygenated storage chamber until use. RNA extraction and reverse transcription-PCR. C57BL/6 mice were killed as described (see above, VNO preparation). Brain, heart, and VNO tissue samples were removed and immediately frozen in liquid nitrogen. RNA was extracted and purified from tissues and cultured LNCaP cells using the RNeasy Mini kit (Qiagen) and DNase digestion. RNA from each sample was quantified using the NanoDrop ND-1000 UV-Vis spectrophotometer (Thermo Fisher Scientific). Five micrograms of total RNA served as a template for oligo-dT-and random hexamer-primed first-strand cDNA synthesis using Moloney murine leukemia virus reverse transcriptase (RT; Invitrogen). PCR was performed in a Mastercycler ep gradient S (Eppendorf) using TaqDNA polymerase (Promega), 1.5 mM MgCl 2 , 0.2 mM of each dNTP, and 100 pM forward/reverse targetspecific oligonucleotide primers. Cycling parameters consisted of an initial denaturation step at 94°C for 5 min, followed by 35 cycles (30 s each) of 94°C (step 1), primer pair-specific annealing temperature (step 2), and 72°C (step 3), and completed by a final extension at 72°C for 5 min. The following primer sequences and annealing temperatures were used to amplify target cDNA: ERG1a, 5Ј-ATGCCGGTGCGGAGGGG-CCAC-3Ј (fwd1)/5Ј-TAGAAGGCGATCTCCACTTTG-3Ј (rev1)/temperature (T) ϭ 55°C; ERG1b, 5Ј-ATGGCGATTCCAACCGGGAAG-3Ј (fwd1)/5Ј-ACAGTCAGGGGCTTGGGACCC-3Ј (rev1)/T ϭ 60°C; ERG2, 5Ј-ATGCCAGTCCGCAGGGGCCA-3Ј (fwd1)/5Ј-CATCCA-CCAGGCAGCGGAAGC-3Ј (rev1)/T ϭ 58°C; ERG3, 5Ј-ATGCCTGTT-CGCAGGGGGCAT-3Ј (fwd1)/5Ј-CTGGGATTATGTGAGTGTTAC-3Ј (rev1)/T ϭ 54°C; MiRP2. 5Ј-ATGGAGACTTCCAACGGGAC-3Ј (fwd1)/5Ј-GACCTGGTACATGAGCCTCC-3Ј (rev1)/T ϭ 56°C. Primers were designed using Clone Manager software (Sci-Ed Software). The annealing temperature for each primer pair was calculated from their individual G/C and A/T content. PCR products were separated by electrophoresis in 1.5% agarose gels containing ethidium bromide (0.5 g/ ml), followed by a second amplification to check for weak or false amplification. For this nested PCR, 0.5 l of the purified initial product served as a template, and the following primer sequences and annealing temperatures were used: ERG1a, 5Ј-TCGCGCCGCAGAACACCTTCC-3Ј (fwd2)/5Ј-CTCCTCTGCGCCCAGCAGGGC-3Ј (rev2)/T ϭ 63°C; ERG1b, 5Ј-CAGGGGCTCTGCAGCCCAGGG-3Ј (fwd2)/5Ј-CTCCTTCAGCAGGAA-GGCGGC-3Ј (rev2)/T ϭ 62°C; ERG2, 5Ј-CCAAAACACTTACTTG-GACAC-3Ј (fwd2)/5Ј-CTTGCGATAGTAGAGGATGTCC-3Ј (rev2)/T ϭ 58°C; ERG3, 5Ј-CTTCCTGGGGACCATCATACG-3Ј (fwd2)/5Ј-CTTGTG-ATAGTAGGTGACC-3Ј (rev2)/T ϭ 56°C; MiRP2, 5Ј-TCAGATCA-TAGACACACGGTTC-3Ј (fwd2)/5Ј-GATGTACACATGATAGGGGTC-3Ј (rev2)/T ϭ 52°C. The identity of PCR products was confirmed by sequencing using the 3130xl Genetic Analyzer and BigDye Terminator version 3.1 Cycle Sequencing kit (Applied Biosystems).
Expression profiling. Oligonucleotide microarray analyses were performed for eight individual RNA samples (four arrays from RNA of pheromone-stimulated mice [(experimental group/(exp)], four arrays of RNA from stimulus-deprived animals [(control group)/(contr)], each containing pooled vomeronasal RNA of five singly housed C57BL/6 male mice. Total RNA was isolated from VNO whole-organ preparations using Trizol reagent (Invitrogen) and the RNeasy Mini kit (Qiagen) according to the manufacturer's instructions. The quality (2100 bioanalyzer, RNA 6000 Pico LabChip; Agilent) and quantity (NanoDrop ND-1000) of this starting RNA were analyzed, and samples were only processed if the quality was satisfactory as indicated by the absence of degradation of ribosomal RNA (28S/18S rRNA ratios ϳ2). Synthesis of double-stranded cDNA, generation of biotinylated cRNA, hybridization to Mouse Genome430_2.0 arrays (Affymetrix), washing (GeneChip Fluidics Station 400), staining, and scanning of the arrays (GeneChip Scanner3000) were done as recommended (Expression_s2_manual; Af-fymetrix). RNA quality was additionally controlled by hybridization to Affymetrix Test 3 chips.
Signal intensities, detection calls (present, absent, and marginal), and pairwise analyses of expression changes between experimental and control arrays were determined from processed array images using the GCOS1.4 software (Affymetrix), exported as Microsoft Excel spreadsheets, and processed using the Significance Analysis of Microarrays (SAM) software tool (available at http://www-stat.stanford.edu/ϳtibs/ SAM). GCOS1.4 software was used to calculate the average noise (2.55 Ϯ 0.1), the average background signal level (54.62 Ϯ 0.84), the average percentages of "present" and "absent" calls (present, 54.96 Ϯ 0.72%; absent, 43.28 Ϯ 0.75%), the average signal level for all probe sets (1364.98 Ϯ 17), the average actin 3Ј/5Ј signal ratio (1.41 Ϯ 0.03), and the average glyceraldehydes-3-phosphate dehydrogenase (GAPDH) 3Ј/5Ј signal ratio (0.98 Ϯ 0.04). To monitor target labeling, poly-A controls (GeneChip Poly-A RNA Control kit) were spiked into RNA samples and called present on all arrays. The detailed quality report is available for download (www.rub.de/signaling). One array from stimulus-deprived controls did not meet conservative quality standards and was thus eliminated from additional analysis resulting in a total of seven replicates. A scaling across all probe sets of a given array to a target intensity of 1000 was included to compensate for variations in the amount and quality of the cRNA samples and other experimental variables. Transcripts were defined as differentially expressed between the stimulated mice and the odor-deprived controls if signal intensities met the following criteria: (1) the gene had to be consistently detected in at least 100% of the samples of either group; and (2) either pairwise statistical analyses of expression changes using a Mann-Whitney test for independent samples showed a p value of p Ͻ 0.05 or random overlap matrix analysis of multiple pairwise comparisons (exp/contr vs contr/contr; under both conditions each transcript is compared 12 times) showed regulated expression only in exp/contr comparisons.
Immunocytochemistry. The VNO was dissected as described (see above, VNO preparation). For preparation of cryosections, the VNO was fixed for 2 h in 4% paraformaldehyde in PBS (150 mM Tris-HCl and 50 mM NaCl, pH 7.4) at 4°C, decalcified overnight in 0.5 M EDTA, and cryoprotected in PBS containing 30% sucrose. The dehydrated VNO was embedded in Tissue Freezing Medium (Leica Microsystems) and sectioned at 25 m on a cryostat (Leica Microsystems). The same protocol was used for sagittal cryosections of the cerebellum.
For single neuron immunostainings, the VNO was minced and digested in 0.19 mg/ml papain and 1 U/ml DNase (Promega) in S 4 for 20 min at 37°C. The tissue was then transferred to S 1 solution and gently triturated using fire-polished glass pipettes saturated with bovine serum albumin (BSA). Nondissociated cells were removed from the cell suspension using BD Falcon Cell Strainer nylon meshes (70 m pore diameter; Becton Dickinson). Dissociated VSNs were transferred to concanavalin A-coated glass-bottom dishes. After 30 min (4°C), VSNs had attached to the bottom of the dishes and were then fixed for 30 min in 4% paraformaldehyde in PBS (4°C).
The following antibodies were used in this study: primary antisera include rabbit anti-KCNH2/anti-KCNH6/anti-KCNH7/anti-KCNE3 (ERG1/ERG2/ERG3/MiRP2; Alomone Labs), rabbit anti-V2R2 (kindly provided by Dr. R. Tirindelli, University of Parma, Parma, Italy), rabbit anti-PDE4A (Novus Biologicals), and rabbit anti-KCNH2 (Santa Cruz Biotechnology). Goat anti-rabbit Alexa Fluor 488, 532, and 633 (Invitrogen) were used as secondary antibodies. Unless indicated otherwise, blocking and staining procedures were identical for both dissociated VSNs and VNO cryosections. Blocking was performed for 1 h (cryosections) or 30 min (dissociated VSNs), respectively, in PBS containing 2% goat serum, 1% gelatin, and 0.2% Triton X-100 (blocking solution). Cells and sections were then incubated for 1 h (room temperature; dissociated VSNs) or overnight (4°C; cryosections) with affinity-purified primary antibody sera (1:500, ERG1/MiRP2/V2R2/PDE4A; 1:250, ERG2/ERG3) in blocking solution, washed in PBS containing 0.05% Triton X-100 (three times for 10 min, one time for 30 min), and incubated for 1 h (sections) or 30 min (VSNs) with Alexa Fluor secondary antibodies (1: 500; Invitrogen). Excess antibodies were removed by washing in PBS containing 0.05% Triton X-100 (three times for 10 min, one time for 30 min). For multilabeling of sections with primary antibodies from the same host species, we adopted a published protocol that uses Fab fragments for blocking and labeling (Leinders-Zufall et al., 2004) . To control for nonspecific staining, experiments in which the primary antibodies were omitted were performed in parallel with each procedure. Fluorescent images were taken using an upright scanning confocal microscope (LSM510-Meta; Zeiss) equipped with a 10ϫ [water immersion, numerical aperture (n.a.) 0.30] and 40ϫ (water immersion, n.a. 0.80) objective. To eliminate cross talk between labels, the multitracking configuration was applied. Endogenously expressed GFP, as well as Alexa Fluor 488, was excited using the 488 nm line of an argon laser, and emitted fluorescence was captured using a bandpass filter (500 -550IR nm). Alexa Fluor 532 and 633 were excited using the 543 and 633 nm line of a helium/neon laser, respectively, and fluorescence was captured using a long-pass filter (560 nm; Alexa Fluor 532) or a bandpass filter (650 -710 nm; Alexa Fluor 633). In some experiments, cell nuclei were stained by brief incubation with DAPI (4Ј,6-diamidino-2-phenylindole) (Invitrogen). In such cases, a Ti:sapphire laser (Mai Tai; Spectra Physics), running at 800 nm, was used as a light source for multiphoton excitation. Digital images were uniformly adjusted for brightness and contrast using Adobe Photoshop CS3 (Adobe Systems).
Immunoblotting. VNOs and control cells and tissues were homogenized in ice-cold S 1 lysis buffer in the presence of Complete Mini protease inhibitor cocktail tablets (Roche) using a Dounce homogenizer. All membrane preparation procedures were performed at 4°C. The homogenate was briefly sonicated and centrifuged for 10 min (1000 ϫ g). The supernatant was collected and ultracentrifuged (2 h, 49,000 ϫ g). The pellet was resuspended in lysis buffer, and protein concentration was determined using a Bradford protein assay kit (Bio-Rad) standardized on BSA. Protein samples were solubilized in Laemmli buffer (20% glycerol, 4% SDS, 125 mM Tris-HCl, and 0.02% bromphenol blue, pH 6.8) and DTT (5%), and equal amounts of protein (35 g) were fractionated by size using 8 -15% (w/v) denaturing SDS-PAGE. Separated proteins were transferred to Immobilon Transfer Membranes (Millipore) or nitrocellulose membrane (Protran; Whatman) using a Criterion Blotter wetblotting system (Bio-Rad). Membranes were washed, stained with Ponceau S to control for protein transfer, and again washed with TBST (150 mM Tris-HCl, 50 mM NaCl, and 0.1% Tween 20, pH 7.4). Blocking was performed in 5% nonfat dry milk/TBST (Bio-Rad) for 1 h. Blots were then incubated overnight at 4°C in 3% nonfat dry milk/TBST with affinity-purified polyclonal rabbit antibodies against human KCNH2 (anti-ERG1; 1:250) and human KCNE3 (anti-MiRP2; 1:750). Membranes were then washed (four times for 15 min) in TBST and incubated at room temperature with horseradish peroxidase-conjugated goat antirabbit IgG (1 h; 1:10,000; Bio-Rad) in 3% nonfat dry milk/TBST. Blots were again washed in TBST (four times for 15 min), and antibody binding was detected using ECL Plus Western Blotting Reagent (GE Healthcare). To control for equal protein loading per lane, membranes were stripped using Restore Western Blot Stripping Buffer (Pierce), washed with TBST, blocked for 1 h in 5% nonfat dry milk/TBST, and reprobed for 1 h in 3% nonfat dry milk/TBST for expression of GAPDH and ␤-tubulin, respectively, using a mouse monoclonal anti-GAPDH antibody (1:30,000; Abcam) and a rabbit polyclonal anti-␤-tubulin antibody (1:2,500; Abcam). Blots were washed in TBST (four times for 15 min) and incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG or anti-mouse IgG (1 h; 1:10,000; Bio-Rad), respectively. After washing in TBST (four times for 15 min), antibody binding was detected as described. After background correction, semiquantitative densitometry measurements of scanned immunoblot band intensities within standard-size rectangular regions of interest were performed using MetaMorph 7.1 imaging software (Universal Imaging Corporation). Calibrated pixel intensities were transformed into an optical density (OD) value according to OD ϭ Log10 [255/(255 Ϫ gray value)]. The OD values of ERG1 and MiRP2 bands were normalized to their associated GAPDH and/or ␤-tubulin controls to compensate for variations in loading and transference.
Electrophysiology. For electrophysiological recordings, VNO slices were transferred to a recording chamber (Slice Mini Chamber; Luigs & Neumann) and visualized using a Leica DM LFSA (Leica Microsystems) fixed-stage upright video microscope equipped with apochromatic water-immersion objectives and infrared-optimized differential interference contrast (DIC) optics. Slices were anchored via stainless steel wires with 0.1-mm-thick lycra threads and continuously superfused with oxygenated solution S 2 (ϳ3 ml/min; gravity flow) at room temperature. Patch pipettes (5-7 M⍀) were pulled from borosilicate glass capillaries with filament and fire-polished ends (1.50 mm outer diameter, 0.86 mm inner diameter; Science Products) on a PC-10 vertical two-step micropipette puller (Narishige Instruments) and fire polished using a MF-830 Microforge (Narishige Instruments). Pipettes were advanced toward individual neurons under optical control applying positive backpressure. After a G⍀ seal was obtained, gentle negative pressure was applied to establish the whole-cell configuration. An EPC-10 amplifier controlled by Patchmaster 2.20 software (HEKA Elektronik) was used for data acquisition. Both pipette (C fast ) and cell membrane (C slow ) capacitance, as well as series resistance (R s ; up to 85% correction, 10 s lag), were monitored and automatically compensated throughout the experiment. Measured C slow values served as an approximation of the cell-surface area for normalization of current amplitudes (i.e., current density). Only neurons exhibiting stable access resistances (change Ͻ10%) were used for analysis. Theoretical liquid junction potentials were calculated using JPCalcW software (Barry, 1994) and automatically corrected on-line.
In voltage-clamp experiments, leak currents were subtracted using a P/-4 procedure. Signals were low-pass filtered (analog three-and fourpole Bessel filters in series) with an effective corner frequency (Ϫ3 dB) automatically adjusted to one-fifth to one-third of the sampling rate (5-20 kHz, depending on protocol). Because ERG channel gating characteristics result in effective inward rectification and ERG conductance is directly related to the external
) were identified and studied with a standard high [K ϩ ] o extracellular solution (S 3 ; calculated Nernst equilibrium potential for K ϩ , Ϫ32.5 mV) (Sacco et al., 2003; Furlan et al., 2007; Hirdes et al., 2005) ,
] o , and blocked voltage-gated Na ϩ channels (TTX; 0.5 M). This treatment, however, demanded that VSNs were analyzed on a one-recording-per-slice basis. Solution exchange (S 2 to S 3 ) after break-in and application of drug-containing solutions was achieved by a custom-made, pressure-driven focal application device consisting of a software-controlled valve bank connected to a "perfusion pencil." Between recordings, cells were kept at a holding potential (V hold ) of Ϫ80 mV. Individual voltage-step protocols are described in Results. To analyze I K(ERG) during AP discharge, prerecorded APs elicited by positive current injections were used as the command waveform (AP clamp).
In current-clamp experiments, slices were perfused with extracellular solution S 2 . The resting membrane potential was measured directly after obtaining access to the cell interior using the software-controlled "gentle switch" of the EPC-10 patch-clamp amplifier. The membrane potential was then set to Ϫ75 mV by injecting a constant holding current (Ϯ3 pA or less). AP discharge patterns were investigated by delivering depolarizing current injections of variable duration and intensity.
Data analysis. Statistical analysis of paired or unpaired two-sample distributions was performed as dictated by data distribution. Results of individual serial randomness tests for normally distributed random samples and subsequent F tests for equal variances determined the use of either t tests or Wilcoxon rank tests. If not stated otherwise, a p value Ͻ0.01 was considered significant, and results are presented as means Ϯ SEM.
Electrophysiological data were analyzed off-line using FitMaster 2.20 (HEKA Elektronik), IGOR Pro 6.03A (WaveMetrics), and Excel (Microsoft) software. Activation curves were fitted by the Boltzmann equation I/I max ϭ I max /{1 ϩ exp [(V 1/2 Ϫ V )/k]}, where V 1/2 is the voltage that produces half-maximal activation and k is the slope factor. Decay time constants () for current deactivation were calculated by fitting individual traces during a fixed time period (2-25 ms after repolarization) to monoexponential functions I (t) ϭ I 1 [exp (Ϫt/ )] ϩ I 0, where I (t) is the current at time t, I 1 is the initial amplitude, is the decay time constant, and I 0 is the residual current. Event detection and spike analysis was performed using the Neuromatic 1.86 software package (written by Jason Rothman) implemented in IGOR Pro 6.03A and MiniAnalysis software (Synaptosoft).
Three-dimensional reconstruction. In voltage-and current-clamp recordings, Alexa Fluor 488 hydrazide (20 M; Invitrogen) was routinely added to the pipette solution for on-line in situ visualization of VSN morphology, post hoc immunocytochemical analysis, and threedimensional (3-D) reconstruction. After break-in, cells were loaded via diffusion. Whole-cell configuration was maintained for at least 20 min to allow for adequate dye filling. After recording, slices were immersion fixed for 30 min at 4°C in PBS containing 4% paraformaldehyde and processed for immunocytochemistry as described above. The morphology of dye-filled cells was studied using an upright scanning confocal microscope (LSM510-Meta; Zeiss) equipped as described above. For 3-D reconstruction of fluorescently labeled VSNs, axial projections of optical section stacks (0.7-1.1 m z-step intervals) were generated as transparencies using a 3-D projection algorithm implemented in the confocal imaging software (Zeiss).
Results

Activity-dependent expression of K
؉ channel genes in the VNO In many neurons, the balance of intrinsic ionic conductances is constantly adjusted as a function of ongoing activity. One mechanism to set a target output range is regulated expression of specific K ϩ channels (Zhang and Linden, 2003) . To determine whether transcription of K ϩ channel genes is activity regulated in the mouse VNO, we surveyed expression profiles of adult male C57BL/6 mice that had been singly housed either in an essentially odor-free environment (deprived group) or exposed to rich sources of pheromonal cues (stimulated group). Stimulation cycles (7 d) were composed of 6 h exposure to fresh male urine (2:00 -8:00 P.M.), 12 h exposure to female-soiled bedding (8:00 P.M. to 8:00 A.M.), and an additional 6 h without stimulation (8:00 A.M. to 2:00 P.M.) to allow for relief from potential sensory adaptation (Fig. 1a) . Vomeronasal K ϩ channel transcription levels were compared between stimulated and deprived tissue using a total of seven Affymetrix microarrays (four experiment and three control replicates), each chip probing pooled mRNA from five animals. Applying conservative quality control and evaluation criteria (see Materials and Methods), 5 K ϩ channel genes were found both consistently detected and differentially expressed ( Fig. 1b ; see supplemental Table 1 , available at www. jneurosci.org as supplemental material, for a summary of results). The most pronounced changes were observed for ERG1 (upregulation) and the modulatory single transmembrane domain ␤-subunit MiRP2 (downregulation), which was reported to inhibit ERG1 currents when coexpressed in Xenopus oocytes (Schroeder et al., 2000) . We next determined vomeronasal expression of ERG1-3 and MiRP2 by RT-PCR. Using specific primers for both ERG1 isoforms (ERG1a and ERG1b), ERG2, ERG3, and MiRP2, we detected transcripts of all genes. Transcript identity was confirmed by nested PCR (Fig. 1c) and sequencing. Bands of the appropriate size were also obtained from cerebellum (Papa et al., 2003; Guasti et al., 2005) and heart (ERG1a, ERG1b, and MiRP2) (Shi et al., 1997) but not from cultured prostate cancer cells (LNCaP).
Next, we aimed to examine activity-dependent changes in ERG1a, ERG1b, and MiRP2 expression on the protein level. In ERG1 immunoblot analyses, the antibody detects two bands at ϳ165 and ϳ100 kDa in VNO protein extracts (supplemental Fig. 1a , available at www.jneurosci.org as supplemental material), corresponding to N-glycosylated ERG1a and ERG1b (Pond et al., 2000; Hirdes et al., 2005) . Equivalent bands were not detected in eye or LNCaP protein extracts. Probing blots of VNO and brain protein with an anti-MiRP2 antibody revealed bands of the expected size (ϳ20 kDa) (McCrossan et al., 2003) in both tissues (supplemental Fig. 1b , available at www. jneurosci.org as supplemental material). An anti-ERG3 antibody detected a single band of ϳ105 kDa in blots of both cerebellum and VNO (supplemental Fig. 1c , available at www.jneurosci.org as supplemental material). An anti-ERG2 antibody, however, stained multiple bands in the expected 100 -110 kDa range in the cerebellum but not the VNO (supplemental Fig. 1d , available at www.jneurosci.org as supplemental material), suggesting no or only marginal translation of ERG2 transcripts in vomeronasal tissue. Using the exact same stimulation/deprivation protocol as described above (Fig. 1a) , pooled VNO protein from stimulated (n ϭ 10) and deprived (n ϭ 12) mice, respectively, was subjected to immunoblot analysis (Fig. 1d,e) . ␤-Tubulin and GAPDH were found at constant levels in microarray experiments and thus served as loading controls. All antibodies detected distinct bands of the expected molecular size. Comparing stimulated and deprived mice, however, revealed substantial differences in band intensity for ERG1a, ERG1b (n ϭ 4), and MiRP2 (n ϭ 3). For stimulus-exposed animals, prominent bands were detected for ERG1a and ERG1b (Fig. 1d) , whereas labeling intensity was much weaker in samples from deprived mice. An opposite regulation was observed for MiRP2 (Fig. 1e) . These results were confirmed by semiquantitative densitometry measurements of scanned immunoblot band intensities (supplemental Fig. 1e) . Thus, the activity-dependent regulation of ERG and MiRP2 K ϩ channel transcripts we identified by microarray profiling is effectively translated into upregulated (ERG1 isoforms) and downregulated (MiRP2) protein levels in the adult mouse VNO.
Coexpression of ERG1, ERG3, and MiRP2 in basal VSNs
To analyze the spatial distribution of vomeronasal ERG and MiRP2 channel subunits, we performed immunocytochemistry in coronal VNO sections from both C57BL/6 and transgenic OMP-GFP mice. In the gene-targeted animals, all VSNs express GFP under the control of the omp promoter (Potter et al., 2001 ). Double-labeling experiments using antibodies against ERG1-3 or MiRP2 together with layer-specific markers of apical neurons [phosphodiesterase 4a (PDE4a) (Lau and Cherry, 2000) ] or basal VSNs [V2R2 (Martini et al., 2001 )] (supplemental Fig. 2a , available at www.jneurosci.org as supplemental material) revealed coexpression of ERG1, ERG3, and MiRP2 in basal neurons (Fig. 2a, b; supplemental Fig. 2c , available at www.jneurosci.org as supplemental material). To control for nonspecific staining, we performed immunocytochemical experiments in which primary antibodies were preadsorbed with their corresponding antigenic peptides (supplemental Fig. 2d ,e, available at www.jneurosci.org as supplemental material). In addition, we routinely performed parallel experiments in which primary antibodies were omitted (supplemental Fig. 3d , available at www.jneurosci.org as supplemental material).
In sections from OMP-GFP mice, merged images of anti-ERG1 and anti-V2R2 labeling show overlapping staining in both the somata and dendritic tips of basal VSNs (Fig. 2a) . In contrast, a spatially restricted pattern was observed by anti-ERG1/antiPDE4a double labeling (supplemental Fig. 2b , available at www. jneurosci.org as supplemental material). PDE4a staining was confined to apical cells, whereas essentially nonoverlapping ERG1 labeling was detected in basal neurons. The same results were obtained using another ERG1 antibody (Santa Cruz Bio- technology; data not shown). Costainings of ERG1 and MiRP2 (supplemental Fig. 2c , available at www.jneurosci.org as supplemental material) as well as ERG1 and ERG3 (Fig. 2b) indicate coexpression of all three subunits. Immunostainings against ERG2, however, showed no VSN-specific labeling (Fig. 2c) . As positive controls, we immunostained sagittal sections of the cerebellum in which expression of all ERG subunits had previously been reported (Papa et al., 2003; Guasti et al., 2005) . Immunoreactivity for ERG1, ERG2, and ERG3 was detected in Purkinje neurons (supplemental Fig. 3a-c , available at www.jneurosci.org as supplemental material). Consistent with semiquantitative immunoblotting results (Fig. 1d) , when parallel ERG1 immunostainings were performed on VNO cryosections from stimulated (n ϭ 3) and deprived (n ϭ 3) mice under the exact same conditions, an increase in both fluorescence intensity and the amount of labeled neurons became apparent (supplemental Fig. 3e , available at www.jneurosci.org as supplemental material).
The subcellular distribution of ERG1 and MiRP2 was assessed in dissociated VSNs from OMP-GFP mice (supplemental Fig.  4a ,b, available at www.jneurosci.org as supplemental material). In immunopositive neurons (n ϭ 5), ERG1 reactivity was evident in the entire cell body. In contrast, MiRP2 staining was most prominent in the soma and dendrite (n ϭ 4) but absent in the knob and microvilli. This pattern confirmed results obtained in whole-organ sections (supplemental Fig. 2c , available at www. jneurosci.org as supplemental material). Together, these data show that both ERG1 isoforms (1a and 1b) as well as ERG3 and MiRP2 are coexpressed in basal neurons of the mouse VNO.
Biophysical "fingerprint" of vomeronasal ERG channels: current activation
We next asked whether ERG channel expression is reflected by voltage-dependent K ϩ currents (I K(ERG) ). Therefore, we obtained whole-cell recordings from optically identified neurons in acute VNO slices . After break-in, physiological saline was replaced by S 3 . Exchange was monitored by the gradual block of voltage-gated Na ϩ inward currents in response to step depolarizations [supplemental Fig. 4c , available at www. jneurosci.org as supplemental material; note the increase in tail current amplitude (arrowhead)]. In all recordings, step protocols were applied before and after incubation with highly specific ERG inhibitors: either the methanesulfonanilide E-4031 (10 M) (Spector et al., 1996) or the scorpion toxin ErgTx-1 (100 nM) (Gurrola et al., 1999) . Digital subtraction of currents recorded in the presence of either drug from control recordings revealed the ERG-mediated component.
To investigate the voltage dependence of quasi steady-state activation, a 750 ms prepulse to variable potentials (Ϫ70 to 60 mV) was followed by a step to Ϫ120 mV (100 ms). After hyperpolarization, rapid recovery from inactivation and slower deactivation induced an E-4031-sensitive tail current in 16 of 27 VSNs (59%) (Fig. 3a) . During depolarization, we observed a substantial E-4031-sensitive steady-state outward current, likely attributable to activation of ERG3. This subunit shows fast activation kinetics and slow steady-state inactivation (Shi et al., 1997; McKay and Huizinga, 2006) , resulting in weak inward rectification (Wimmers et al., 2002) . Eleven of 27 neurons showed no drug-sensitive current (Fig. 3b) . To ensure that diminished tail currents did not result from current rundown, we performed controls in the absence of inhibitors (supplemental Fig. 4d , available at www. jneurosci.org as supplemental material). Up to 10 min, essentially no rundown was observed.
When peak tail current density is plotted as a function of prepulse depolarization (Fig. 3c) , a similar voltage dependence is seen for E-4031-sensitive VSNs (n ϭ 16 of 27) and ErgTx-1-sensitive neurons (n ϭ 14 of 18). Normalization of tail currents (Fig. 3d) -1) , respectively. These data show that, although channels begin to activate at subthreshold potentials, a considerable membrane depolarization is required to evoke substantial channel activation.
In addition to voltage-dependent gating characteristics, ion channel function is determined by gating kinetics. To investigate ERG channel activation kinetics in VSNs, we applied an envelope of tail current protocol (Schonherr et al., 1999; Sturm et al., 2005) . Depolarizing prepulses (40 mV) of increasing duration (5-2310 ms; increment factor, 1.55) were followed by hyperpolarization to Ϫ120 mV (Fig. 3e) . When current densities were plotted as a function of prepulse duration (Fig. 3f,g ), I K(ERG) amplitude increased exponentially with a time constant act ϭ 194 ms (n ϭ 13). Similar values were reported for recombinant rERG channels [ act ϭ 95 ms (rERG3) to 215/123 ms (rERG1a/ rERG1b)] (Hirdes et al., 2005) . However, we observed a significant current (Ϫ37.3 Ϯ 11.2 pA/pF) even at 5 ms depolarizations (Fig. 3f ) , corresponding to 34.4 Ϯ 5.3% of open channels [current normalization (I/I max ) on a semilogarithmic scale] (Fig. 3g) . Half-maximal activation was observed after 25.8 ms. These results indicate that, provided a substantial membrane depolarization, a considerable fraction of vomeronasal ERG channels displays a relatively rapid time course of activation.
Biophysical fingerprint of ERG channels: current availability and deactivation
The combination of fast recovery from inactivation and relatively slow deactivation is a characteristic feature of ERG channels (Schwarz and Bauer, 2004) underlying their role in membrane repolarization and modulation of excitability. Therefore, we next studied vomeronasal ERG current availability after repolarization. VSNs were depolarized (40 mV) for 500 ms to fully activate/ inactivate ERG channels. After repolarization to variable potentials (Ϫ10 to Ϫ120 mV, 100 ms), drug-sensitive tail current amplitudes and deactivation kinetics are clearly voltage dependent (Fig. 4a) . Forty-nine percent (25 of 51; E-4031) and 53% (8 of 15; ErgTx-1) of all neurons, respectively, exhibited ERGmediated currents (Fig. 4a) , whereas no currents were detected in the remaining 26 (E-4031) and 7 (ErgTx-1) VSNs (Fig. 4b) . I K(ERG) quasi steady-state inactivation curves were derived from peak current densities and fitted by the Boltzmann equation. No significant amplitude differences (one exception at Ϫ30 mV), similar V 1/2 values for half-maximal recovery from inactivation (E-4031, Ϫ62.3 mV; ErgTx-1, Ϫ63.8 mV), and slope factors (E-4031, k ϭ 19; ErgTx-1, k ϭ 17) illustrate the effective isolation of vomeronasal ERG currents using either blocker (Fig. 4c,d ). Using S 3 , the calculated Nernst equilibrium potential for K ϩ is Ϫ32.5 mV. Individual normalized I K(ERG) availability curves reversed, on average, at Ϫ30.5 Ϯ 1.5 mV (ErgTx-1; n ϭ 6) and Ϫ26.7 Ϯ 1.3 mV (E-4031; n ϭ 10; p ϭ 0.078), respectively, confirming the K ϩ selectivity. Notably, at potentials of Ϫ60 mV or less, I K(ERG) deactivation was not complete after 100 ms (Fig. 4a,  expanded traces) . When plotting average amplitudes, at 95 Ϯ 5 ms after repolarization, versus membrane potential (Fig. 4e) , this "steady-state" current becomes apparent (E-4031, n ϭ 13; ErgTx-1, n ϭ 8).
On expanded coordinates (Fig. 4a) , the voltage dependence of deactivation becomes evident. Tail current decay was fitted by a single exponential function (gray dashed line) to determine deactivation time constants ( deact ). Currents elicited by strong hyperpolarization (Fig. 4a , Ϫ120 mV trace) deactivated faster than currents evoked by step repolarization to less negative potentials (Fig. 4a, Ϫ90 mV trace) . This characteristic of ERG channels was quantified by plotting deact versus the repolarization potential (Fig. 4f,g ). On a semilogarithmic scale, the voltage dependence of deact was linear (Fig. 4f ) . Normalization to values recorded at Ϫ60 mV (E-4031: 21.5 Ϯ 2.6 ms, n ϭ 16; ErgTx-1: 20.3 Ϯ 5 ms, n ϭ 5) reveals no inhibitorrelated differences (Fig. 4g) . Together, substantial ERG-mediated K ϩ current, consisting of both a deactivating tail and a steady-state current component, is available in basal VSNs during fast repolarization to subthreshold membrane potentials.
The ERG1 channel subunit is a major contributor to vomeronasal I K(ERG)
K ϩ channel profiling and semiquantitative immunochemistry revealed activitydependent upregulation of ERG1 expression (Fig. 1) . Therefore, we aimed to dissect the role of this specific subunit in generation of vomeronasal ERG currents using a pharmacological approach. In contrast to the less selective agents E-4031 and ErgTx-1, the recombinant peptide rBeKm-1 completely blocks ERG1 at nanomolar concentrations without affecting other channels including ERG3 (Korolkova et al., 2001; Restano-Cassulini et al., 2006) . We, thus, repeated various experiments shown in Figures 3 and 4 using rBeKm-1 (100 nM) to study activation, recovery from inactivation, and deactivation of isolated ERG1-mediated currents (Fig. 5) . Eight of 15 VSNs (53%) showed rBeKm-1-sensitive currents. Quasi steadystate activation was compared with data obtained when blocking all subunits using E-4031 (Fig. 5a ). We found significantly smaller rBeKm-1-sensitive current amplitudes at positive potentials. Activation curves showed similar V 1/2 values for currents isolated by rBeKm-1 (Ϫ18.6 mV) and E-4031 (Ϫ13.8 mV). However, the slope of the rBeKm-1 curve (k ϭ 23.8) was considerably more shallow than for currents isolated by E-4031 (k ϭ 17). In experiments addressing current availability after repolarization (Fig. 5b) , significantly , Representative whole-cell patch-clamp recording traces. Tail currents were elicited in the absence (control) and presence of E-4031 (10 M) by hyperpolarization to Ϫ120 mV (inset, pulse protocol). ERG-mediated currents (n ϭ 16) are computed as drug-sensitive components after digital off-line subtraction (control Ϫ E-4031). Eleven neurons showed no drug-sensitive currents (b). c, d, Quasi steady-state activation curves of both E-4031-sensitive (filled circles; n ϭ 16) and ErgTx-1-sensitive (100 nM; filled triangles; n ϭ 14) currents. Curves illustrate average current densities (c) or normalized current amplitudes (d; I/I max ) versus prepulse potential. Data points are fitted by the Boltzmann equation (see Results). With one exception (c; Ϫ40 mV), no significant differences in current isolation were observed between inhibitors. e-g, Time course of vomeronasal ERG current activation (inset, "envelope of tail currents" pulse protocol). e, Representative original recording after digital current subtraction (control Ϫ E-4031). On expanded coordinates (dotted square area), note the increase in current amplitude during prolonged depolarization. f, Average tail current densities increased with prepulse duration (monoexponential fit extrapolated to 0 pA/pF: act ϭ 194 ms; n ϭ 13). g, On a logarithmic time scale, normalized tail currents (I/I max ) increase in a linear manner (half-maximal activation at a prepulse duration of 25.8 ms).
decreased amplitudes are observed in rBeKm-1-treated VSNs after repolarization to membrane potentials of Ϫ80 mV or less. Moreover, half-maximal recovery from inactivation and slope factors were different (E-4031: Ϫ60.3 mV, k ϭ 19; rBeKm-1: Ϫ71.5 mV, k ϭ 25). Notably, no differences in the nondeactivation current component were found using either treatment (Fig. 5c) , suggesting that the steady-state current is predominantly, if not exclusively, mediated by homomeric or heteromeric ERG1 channels. In summary, these data indicate that the ERG1 subunit(s) contributes substantially to the total ERG-mediated current. However, a small but significant fraction is carried by rBeKm-1-insensitive subunits.
I K(ERG) is selectively expressed in basal VSNs
Immunochemistry revealed that ERG subunits are exclusively found in basal neurons ( Fig. 2; supplemental Figs. 2b-e, 3e, available at www.jneurosci.org as supplemental material). If so, ERG-mediated currents should only be expressed in ϳ50% of all VSNs. Indeed, we observed I K(ERG) in 53% (41 of 78; E-4031), 67% (22 of 33; ErgTx-1), and 53% (8 of 15; rBeKm-1) of investigated neurons. To consolidate these findings, we labeled several VSNs (n ϭ 11) during voltage-clamp analysis by adding Alexa488 hydrazide (20 M) to the pipette solution. This allowed on-line in situ visualization of VSN morphology (Fig. 6a, left and middle) , post hoc immunocytochemical analysis (Fig. 6b-f ) , and 3-D reconstruction (Fig. 6a , right (n ϭ 7) (supplemental Movie 1, available at www.jneurosci.org as supplemental material). All labeled neurons exhibited an intact cytoarchitecture. Given the rather diffuse zonal boundary in the VNO ( Fig. 2; supplemental Fig. 2 , available at www. jneurosci.org as supplemental material) (Martini et al., 2001; Leinders-Zufall et al., 2004) , it was, however, impossible to infer basal or apical identity of a given neuron simply from in situ visualization. We therefore determined cell identity by post hoc immunocytochemistry using anti-V2R2 (Fig. 6b,d ), anti-PDE4a (Fig. 6c,e) , and anti-ERG1 (Fig. 6f ) antibodies. All labeled VSNs that showed ERG-mediated currents (n ϭ 8) were immunopositive for either ERG1 (n ϭ 4) or V2R2 (n ϭ 2) or showed no PDE4a staining (n ϭ 2), respectively (Fig. 6b,c) . In contrast, cells that exhibited no current (n ϭ 3) were either negative for V2R2 (Fig. 6d) or ERG1 (Fig.  6f ) or strongly stained by the anti-PDE4a Figure 4 . Voltage dependence of ERG channel deactivation. a-d, ERG current availability depends on the degree of repolarization. a, Representative original tail currents recorded during repolarization steps to variable membrane potentials (Ϫ10 to Ϫ120 mV; inset, pulse protocol). Recordings are shown under control conditions, in the presence of E-4031 (10 M) and after digital off-line subtraction (control Ϫ E-4031). On expanded coordinates (dotted square area; left), the voltage dependence of current availability becomes obvious (n ϭ 25). b, In 26 VSNs, essentially no drug-sensitive currents could be isolated. c, d, Quasi steady-state I K(ERG) inactivation curves derived from peak current densities (c) or normalized current amplitudes (d; I/I max ) and plotted as a function of the repolarization voltage [filled circles, E-4031, n ϭ 25; filled triangles, ErgTx-1 (100 nM), n ϭ 8]. Data points are fitted by the Boltzmann equation. With one exception (c; Ϫ30 mV), no significant differences are observed between curves derived using either inhibitor. e, Steady-state current density after 95 ms of repolarization (E-4031, n ϭ 13; ErgTx-1, n ϭ 8). At membrane potentials of Ϫ60 mV or less, a nondeactivating or slowly deactivating current is recorded (a; expanded dotted square area; right). Trend lines were extrapolated using a Gauss function. f, g, Voltage dependence of deactivation kinetics (filled circles, E-4031, n ϭ 16; filled triangles, ErgTx-1, n ϭ 5). deact was determined by single-exponential fits during a fixed time period (2-25 ms after repolarization). On a semilogarithmic scale (f ), deact versus repolarization potential shows a linear relationship. When deact values are normalized to data obtained at Ϫ60 mV (g), no differences in deactivation kinetics are observed using either ERG inhibitor. (Fig. 6e) antibody. ERG-mediated currents are thus unique to basal V2R-expressing neurons.
Regulated transcription is effectively translated into changed protein functionality
We next asked whether the reduced ERG1 channel expression in stimulus-deprived mice (Fig. 1) is reflected in VSN electrophysiology. To address this question, we recorded ERG-mediated currents in optically identified basal VSNs ) from stimulus-deprived animals (n ϭ 9). Using the same pulse protocols as shown in Figures 3a and 4a , we recorded both E-4031-and rBeKm-1-sensitive tail currents as a function of either prepulse (Fig. 6g,i) or repolarization (Fig. 6h,j) potential, respectively. Indeed, using either E-4031 to isolate total ERG currents or rBeKm-1 to specifically isolate the ERG1-dependent component, current densities were significantly reduced in VSNs from deprived mice. When data from deprived animals (E-4031) were fitted by the Boltzmann equation, the slopes of both the I K(ERG) activation (k ϭ 20) and the availability curve (k ϭ 27) were considerably shallower than observed for control neurons (k ϭ 17/ 19) (Fig. 6g,h) , indicating not only a reduced density of functional channels but also a relative change in subunit composition. Notably, when ERG1-specific currents were isolated from VSNs of control versus deprived mice using rBeKm-1, we observed significantly reduced current densities in deprived mice (Fig. 6i,j) , indicating that the substantial reduction in total I K(ERG) in VSNs from stimulus-deprived mice is, at least in part, attributable to decreased ERG1 expression. This conclusion is supported by the fact that we never observed a nondeactivating current in deprived mice. Because rBeKm-1-sensitive steady-state currents were almost indistinguishable from controls (Fig. 5c) , this lack of a steady-state current supports the concept of ERG1 being a critical subunit for incomplete deactivation at hyperpolarized voltages.
I K(ERG) contributes to the late phase of AP repolarization in VSNs
Several biophysical characteristics of vomeronasal ERG currents suggest a potential function in AP repolarization. First, considerable membrane depolarization (e.g., during AP overshoot) is required to evoke substantial activation (Fig. 3a,d) . Second, significant currents are observed even at preceding depolarizations as short as 5 ms (Fig. 3f ) . Third, little inactivation occurs during depolarization (Fig. 3e) . Do ERG channels thus contribute to spike repolarization in VSNs? To clarify this question, we recorded E-4031-sensitive currents using the AP clamp technique. Prerecorded AP trains elicited by positive current injection into VSNs were applied as the command waveforms (black traces). This way, vomeronasal ERG channels experience the same trajectory of voltage as during naturally occurring APs (Bean, 2007) . Figure 7a shows a drug-sensitive current that is rapidly activated and shifted from outward to inward during the repolarizing phase (n ϭ 24). On expanded coordinates (Fig. 7a, right) , this current reversed close to the calculated Nernst K ϩ equilibrium potential of Ϫ32.5 mV (red dotted lines), reached a peak close to the point of maximal repolarization (Ϫ70 mV; black dotted lines), and decayed exponentially with a mean time constant of deact ϭ 17.9 Ϯ 4.3 ms. We next asked whether the duration of interspike episodes affects the ERG current amplitude. Frequency-dependent ERG current accumulation has previously been observed (Chiesa et al., 1997; Schonherr et al., 1999) . When a train of VSN APs, showing spike frequency adaptation during constant current injection, was used as a stimulus template, ERG amplitudes decreased with prolonged interspike intervals (Fig. 7b) (control/E-4031, n ϭ 14; control/rBeKm-1, n ϭ 14; deprived/rBeKm-1, n ϭ 9). At discharge intervals longer than ϳ150 ms, however, peak current densities remain relatively stable, indicating that at frequencies Ն7 Hz incomplete ERG channel deactivation between spikes could lead to current accumulation. Moreover, AP-driven ERG currents are strongly ERG1 dependent (Fig. 7b, right) . Total I K(ERG) amplitudes (E-4031) and the ERG1-specific current component (rBeKm-1) are not statistically different, although the latter tends to be consistently smaller. In VSNs from deprived animals, however, ERG1-dependent current flow during AP discharge is strongly reduced (red graph). In summary, these data Figure 5 . Substantial contribution of the ERG1 channel subunit to vomeronasal I K(ERG) . a, Quasi steady-state activation of vomeronasal ERG currents (see Fig. 3c ) [filled circles, E-4031 (10 M), n ϭ 16; filled squares, rBeKm-1 (100 nM), n ϭ 8]. Current densities are shown as a function of prepulse potential and fitted by the Boltzmann equation. At depolarization to positive voltages (10 -40 mV and 60 mV), rBeKm-1-sensitive amplitudes are significantly smaller than currents isolated using the nonsubunit-selective agent E-4031 ( p Ͻ 0.05). b, Significant differences in channel availability after repolarization (filled squares, rBeKm-1, n ϭ 8; filled circles, E-4031, n ϭ 25). Inactivation curves show significantly decreased peak densities for ERG1-specific currents at potentials of Ϫ80 mV or less ( p Ͻ 0.05). c, Similar steady-state current characteristics are detected using either pharmacological treatment. Trend lines are calculated using a Gauss function.
show that considerable ERG1-dependent currents flow during the late repolarizing phase of vomeronasal AP discharge.
I K(ERG) extends the dynamic range of the vomeronasal stimulus-response function
What is the physiological relevance of ERG channel activation during AP firing? We addressed this question by recording VSN input-output relationships in currentclamp configuration (supplemental material, available at www.jneurosci.org) under physiological ionic conditions. The majority of VSNs were spontaneously active at rest. We therefore injected a constant hyperpolarizing current (Ϫ0.5 to Ϫ3 pA) to keep V M as close as possible to Ϫ75 mV, thereby abolishing spontaneous firing. First, we investigated VSN output in response to a naturally occurring receptor current profile. We designed a current injection protocol that mimicked a basal VSN response that we recorded after application of diluted urine (Fig. 8a, gray box, top). This protocol was applied for five cycles of increasing duration (Fig. 8a , gray box, bottom, a-e). VSN firing patterns were analyzed in the absence and presence of E-4031 (10 M). Six of 13 VSNs showed a dramatic effect on AP firing. In these neurons, the number of spikes was significantly reduced after drug incubation (Fig. 8b) . Notably, this effect was most pronounced during the initial phase of high-amplitude current injection (25 Ϫ 7 pA). Here, we frequently observed that VSNs ceased firing after one or a few initial spikes, but returned to a tonic discharge jneurosci.org as supplemental material). b-f, Layer-specific classification of Alexa488-labeled VSNs by post hoc immunocytochemistry. V2R2, PDE4a, or ERG1 counterstaining shows that VSNs that exhibited ERG currents in previous voltageclamp recordings (n ϭ 8) are V2R2 positive (b) or PDE4a negative (c), respectively, whereas neurons that showed no ERGdependent currents are either negative for V2R2 (d) or ERG1 (f ) or PDE4a positive (e). g-j, ERG currents are reduced in VSNs of stimulus-deprived mice. g, i, Activation curves of either E-4031-sensitive (g) or rBeKm-1-sensitive (i) ERG currents from stimulus-deprived (filled diamonds; g, n ϭ 9; i, n ϭ 11) and control (g, filled circles, n ϭ 16; i, filled squares, n ϭ 8) animals. At depolarizations of Ϫ40 mV or more (g) or Ϫ10 mV or more (i), respectively, the reduction is highly significant ( p Յ 0.005). h, j, I K(ERG) availability curve for stimulus-deprived (filled diamonds; h, n ϭ 8; j, n ϭ 7) and control (h, filled circles, n ϭ 25; j, filled squares, n ϭ 8) mice. Current densities are significantly smaller after repolarization to voltages of Ϫ60 mV or less (h) or Ϫ30 mV or less (j), respectively ( p Յ 0.05). a, Axon; BV, blood vessel; d, dendrite; k, knob; L, lumen; ML, microvillous layer; p, patch pipette; s, soma; SCL, sustentacular cell layer; SE, sensory epithelium.
pattern during small-amplitude current injection (7 Ϫ 2 pA) (Fig. 8a, traces d and e) . Analog results were obtained from analysis of firing patterns in deprived mice (Fig. 8a,b , red) (n ϭ 36). These data suggest that, by ensuring a sufficient level of membrane repolarization, vomeronasal ERG currents could play a critical role during periods of strong sensory activation.
If the above hypothesis is true, the effect should become more pronounced with increased spike frequencies. Indeed, when the firing rate is analyzed as a function of current injection amplitude (4 -40 pA; 1 s duration), the mean spike frequencies are significantly reduced in the presence of E-4031 at amplitudes Ն8 pA (Fig. 8c,d ) (n ϭ 11 of 15 VSNs). This effect of pharmacological ERG channel inhibition mimics the impaired AP firing phenotype observed in VSNs from stimulus-deprived animals (Fig.  8c,d , red) (n ϭ 30). However, maintenance of a constant resting potential (supplemental Fig. 4e , available at www.jneurosci.org as supplemental material) (n ϭ 12) and spontaneous activity (supplemental Fig. 4f , available at www.jneurosci.org as supplemental material) (n ϭ 3) were essentially unaffected by ERG channel inhibition. We thus conclude that basal VSNs express I K(ERG) to guarantee an appropriate input-output relationship at intermediate to high levels of sensory stimulation.
To substantiate this concept, we analyzed changes in the "anatomy" of single spikes both during ERG channel inhibition (supplemental Fig. 5a -c, available at www.jneurosci.org as supplemental material) and in stimulated compared with deprived mice (supplemental Fig. 5d-f , available at www.jneurosci.org as supplemental material). Single APs were elicited by repeated injection of suprathreshold current (10 pA; 45 ms; 50 cycles at 5 ms intervals). Supplemental Figure 5a (available at www. jneurosci.org as supplemental material) shows representative examples of 50 normalized and averaged spikes of the same neuron in the absence (black trace) or presence (red trace) of E-4031, respectively. Here, spike width is increased from 5.05 ms (control) to 5.85 ms (E-4031). Eleven VSNs were examined for both halfwidth (supplemental Fig. 5c , available at www.jneurosci.org as supplemental material) and maximal membrane repolarization (supplemental Fig. 5b , available at www.jneurosci.org as supplemental material) during current injection. Because the same cells were also used for experiments shown in Figure 8 , c and d, we were able to categorize these VSNs as either drug sensitive (n ϭ 7; red data points) or insensitive (n ϭ 4; black data points). E-4031-sensitive neurons show a significant shift of the maximally repolarized membrane potential toward more depolarized values (control, Ϫ67.1 Ϯ 1.4 mV; E-4031, Ϫ58.8 Ϯ 1.3 mV; p ϭ 0.008) and a significant increase in half-width (control, 4.8 Ϯ 0.18 ms; E-4031, 5.66 Ϯ 0.44 ms; p Ͻ 0.005)). A similar broadening of spike width during ERG channel inhibition has been shown for immature Purkinje neurons (from 5.1 to 6.3 ms) (Sacco et al., 2003) . Again, when comparing single VSN spikes from stimulated (n ϭ 13) versus deprived (n ϭ 21) mice, the deprivation phenotype (supplemental Fig. 5d-f , available at www.jneurosci.org as supplemental material) matches the effects of pharmacological treatment observed in control VSNs. Together, these data strongly suggest that vomeronasal ERG channels are important determinants of AP shape and VSN set-point excitability.
Discussion
Despite the critical role of the accessory olfactory system in regulation of social and reproductive behaviors, many physiological mechanisms underlying sensory signaling in VSNs remain unclear. Here, we show that basal vomeronasal neurons display a previously unrecognized form of homeostatic plasticity by regulating ERG K ϩ channel expression in an activity-dependent manner. These channels emerge as important determinants of VSN excitability and thus of sensory gain control in the accessory olfactory system.
Neuronal ERG channel physiology is poorly understood (Sanguinetti and Tristani-Firouzi, 2006) and, so far, functional ERG channels have not been described in peripheral sensory neurons. Our results show that both ERG1 isoforms, ERG3 and the auxiliary ␤-subunit MiRP2, are coexpressed in basal VSNs. ERG3 and MiRP2 expression were primarily confined to VSN somata, whereas ERG1 staining was also found in the dendritic tips. Overlapping expression suggests that currents could be determined, at least in part, by heteromeric ERG channels (Wimmers et al., 2001) , potentially forming complexes with pluripotent modulatory MiRP2 ␤-subunits (McCrossan et al., 2003) . As shown by . A single representative event (dotted square) is shown at higher resolution (right). During AP discharge, an outward current is activated that reverses direction during repolarization, reaches a maximum at Ϫ70 mV (black dotted lines), and decays exponentially. The observed reversal potential is close to the calculated Nernst K ϩ equilibrium potential of Ϫ32.5 mV (red dotted lines). b, Representative AP clamp recording (left; red trace) at a command voltage spike train displaying frequency adaptation (black). Quantitative analysis (right) of ERG current amplitudes versus interspike intervals is shown. Total I K(ERG) is isolated from control VSNs using E-4031 (10 M; n ϭ 14; black circles, solid line), whereas ERG1-dependent currents are isolated by rBeKm-1 [100 nM; black squares, dashed line (control, n ϭ 14); red diamonds, solid line (deprived, n ϭ 9)]. Current densities decrease exponentially with prolonged interspike intervals. In VSNs from deprived animals, I K(ERG) is significantly reduced ( p Յ 0.05).
immunoblotting, both ERG1 isoforms are found in the VNO. The exclusive staining of basal VSNs suggests that both splice variants are coexpressed in a given cell and potentially coassemble in heteromeric complexes (Guasti et al., 2005) . However, we can neither rule out selective isoform expression in subgroups of basal VSNs nor exclude segregated homomeric expression in individual neurons.
To address the functional implications of vomeronasal ERG channel expression, targeted gene disruption represents one possible strategy. However, homozygous ERG1-deficient mice die early in development Salama and London, 2007) . We therefore used a pharmacological approach. Given the severe pathophysiological phenotype of ERG channel gene mutations, the pharmacological profile of ERG channels has been intensely scrutinized (Sanguinetti and Tristani-Firouzi, 2006) . In this study, we used E-4031 and the two unrelated peptide toxins ErgTx-1 and rBeKm-1 for pharmacological current dissection. Both E-4031 and ErgTx-1 are highly ERG specific, but not sufficiently subunit selective. In contrast, rBeKm-1, a closed channel blocker, discriminates between ERG1 (IC 50 , ϳ3 nM) and ERG3 (IC 50 , ϳ1 M) (Korolkova et al., 2001 ). All inhibitors effectively isolated ERG-mediated currents from basal VSNs. For E-4031, ERG selectivity results from high-affinity binding to two inner pore aromatic residues that are substituted in other K ϩ channels. ErgTx-1 also interacts with the channel pore and, at the concentration used, does not affect other K ϩ channels including members of the closely related EAG family. E-4031 and ErgTx-1 did not display significant differences in inhibition potency, whereas rBeKm-1 (100 nM) isolated substantial, although significantly smaller, currents. These results suggest that a large fraction of vomeronasal ERG current depends on functional ERG1 channels, either as homomers or crucial subunits of heteromeric channels.
In several kinetic aspects, vomeronasal ERG channels differ from heterologously expressed channels. Effective channel activation, even during 5 ms voltage steps, requires substantial depolarization (V 1/2 : E-4031, Ϫ13.8 mV; ErgTx-1, Ϫ7.1 mV). Similar values were reported for recombinant ERG1 (Lees-Miller et al., 1997; Hirdes et al., 2004; Sturm et al., 2005) , whereas more negative V 1/2 potentials (approximately Ϫ50 mV) were described for ERG3 (Hirdes et al., 2005; Sturm et al., 2005) . Vomeronasal ERG currents deactivated considerably faster than recombinant channels (Wimmers et al., 2002; Sturm et al., 2005) . Accelerated deactivation, however, has also been observed for other endogenous Figure 8 . ERG channels determine the output range of basal vomeronasal neurons. a, Representative AP discharge patterns induced by current injections. The injection protocol (gray box) mimics a prerecorded VSN receptor current profile in response to focal application of diluted urine (1:100; red trace). High-frequency firing is impaired in response to current injections both after ERG channel inhibition and VSNs of stimulus-deprived animals. Lowercase letters indicate corresponding injection protocols. b, Mean number of spikes versus current injection length (a) in control VSNs (n ϭ 6; black circles, solid line), after ERG channel inhibition (n ϭ 6; black diamonds, dashed line), and in VSNs from deprived animals (n ϭ 36; red diamonds, solid line). Drug incubation and deprivation significantly reduce the total spike count at durations Ն500 ms ( p Յ 0.05). c, Typical firing responses induced by constant 1 s depolarizing current steps of variable amplitude (4 -40 pA; 4 pA increments). Note the continuous decline in AP amplitude (deprivation/ERG channel inhibition) as a putative result from reduced membrane repolarization and, consequentially, insufficient recovery from Na ϩ channel inactivation. d, Mean firing frequency versus current amplitude ( f-I curve). For amplitudes Ն4 pA (deprived, n ϭ 30) or Ն8 pA (E-4031, n ϭ 11), respectively, the frequency is significantly reduced ( p Ͻ 0.005). Under control conditions, firing rates approximate a maximum frequency of ϳ25 Hz. After deprivation or ERG channel inhibition, the f-I curve shows a more bell-shaped appearance.
mouse ERG currents (McKay and Huizinga, 2006; Yeung and Greenwood, 2007) . In general, ERG1b and ERG3 deactivate much faster than ERG1a and ERG2 (Lees-Miller et al., 1997; Hirdes et al., 2005) , and there are significant species variations in deact (Tseng, 2001) . Assuming that VSN subunits form heteromeric channels, activation and deactivation will be dominated by the faster subunit(s) (Wimmers et al., 2001 (Wimmers et al., , 2002 . In principle, differences between vomeronasal and recombinant channels could also result from processes such as phosphorylation, Ca 2ϩ -dependent channel modulation, or lipid interaction. Given the regulated coexpression of MiRP2, however, it is tempting to speculate that this pluripotent modulator of K ϩ channels coassembles with vomeronasal ERG channels, thus altering their gating. Together, the observed channel properties are well suited to shape vomeronasal AP discharge. VSN spikes display large overshoot and last considerably longer than typical central neuron APs (Sacco et al., 2003; Ukhanov et al., 2007) , providing the depolarization level and time course required for channel activation. In contrast, fast deactivation and negligible steady-state "window" current at V rest argue against a role in VSN resting potential maintenance.
Pheromonal information translates into specific discharge patterns. The VSN output parameter space is multidimensional [i.e., information can be encoded by discharge duration (temporal coding), frequency (rate coding), or both]. These parameters are dictated by the AP duration, shape, and associated refractory period and are thus set by the individual currents contributing to an AP. We dissected this "internal anatomy" (Bean, 2007) of basal VSN spikes using the AP clamp technique and isolated ERG currents maximally activated during the late phase of repolarization. This current deactivated with an average time constant close to the deact value observed after step repolarization to Ϫ60 mV. Amplitudes varied as a function of the interspike interval at frequencies Ն7 Hz, showing larger currents at shorter interspike episodes. Theoretically, this could reflect channel desensitization during the initial phase (ϳ1 s) of spiking. However, when prerecorded APs with smaller, although increasing, intervals (55-135 ms) were applied as the command voltage, amplitudes decreased with prolonged intervals throughout the recording (data not shown). We therefore conclude that, at high-frequency discharge, incomplete interspike deactivation can lead to current accumulation [similar to observations reported by Chiesa et al. (1997) and Sacco et al. (2003) ]. Recently, accumulation of recombinant ERG1 and ERG3 currents was shown already during short simulated AP bursts (6 ms duration, 20 ms intervals) (Sturm et al., 2005) . Basal VSNs display frequency saturation at ϳ25 Hz. Thus, minimum intervals of ϳ40 ms and fast deactivation set a limit for maximum current accumulation.
How important are ERG currents for a stable input-output relationship? VSNs are remarkably sensitive to current injection, with a few picoamperes leading to repetitive firing (Liman and Corey, 1996) . Yet, pheromonal stimulation can induce receptor currents of up to tens of picoamperes (this study; Inamura and Kashiwayanagi, 2000) . In addition, the constricted space of the VNO lumen and putatively slow stimulus exchange likely result in a prolonged presence of pheromonal cues. Therefore, VSNs need to faithfully integrate prolonged sensory input of variable magnitude. When basal VSNs were stimulated by injection profiles that mimic endogenous receptor currents, AP output changed dramatically after ERG channel inhibition. During highamplitude current injection, VSNs frequently ceased firing after one or a few spikes. More importantly, such impaired AP discharge was similarly observed in VSNs of stimulus-deprived animals. Constant current injections confirmed that ERG currents provide a critical repolarizing conductance at intermediate to high stimulation levels. We thus conclude that, by ensuring repolarization sufficient to relieve Na ϩ channels from inactivation, ERG currents extend the dynamic response range of basal VSNs.
Neurons display compensatory feedback mechanisms that reestablish a set-point functionality in response to altered sensory input. Output stability within optimal firing rate limits is achieved by modulating ion channel density, distribution, or function. Thus, de novo channel synthesis is frequently regulated to gradually restore firing properties on a longer time scale. Experimentally, compensatory feedback is frequently induced by chronic activity deprivation over a longer time scale (i.e., hours to days) (Davis, 2006) . This concept provided the temporal framework for investigating the consequences of stimulus deprivation in the mouse VNO.
How can sensory input trigger changes in gene transcription? Current models propose a key role of intracellular Ca 2ϩ , a signal well correlated with neuronal activity (Turrigiano, 1999) . In VSN somata, responses to pheromonal stimuli induce robust Ca 2ϩ transients (Spehr et al., 2002; Chamero et al., 2007) . Ca 2ϩ accumulation during periods of high sensory activity or the lack of such signals during stimulus deprivation could readily control ion channel gene transcription.
In the present study, we focused on activity-dependent changes in K ϩ channel expression because K ϩ conductance changes have frequently been implicated in homeostatic compensation (Davis, 2006) . Initially, we performed microarray analyses to achieve a genetic high-throughput. Compared with data obtained (e.g., in cancer expression profiling), we observed relatively low changes. In brain tissue microarray experiments, however, similarly low changes even for strongly regulated genes are rather the rule than the exception (Mirnics, 2001 ). Regulated expression is especially difficult to discern if only subpopulations of cells express the target gene (Mirnics and Pevsner, 2004) . The small, although highly significant, changes we detected are therefore not surprising. Our conservative approach to data analysis (see Materials and Methods) might, however, mask further "biologically true" expression changes.
Because there is no simple quantitative correlation between gene transcription and protein translation (e.g., compare ERG2 microarray and RT-PCR data with immunochemistry results), microarray findings have to be confirmed on the protein level. Although a positive correlation between mRNA and protein levels is frequently observed, several studies have shown no or even a negative correlation, resulting from different mechanisms and pathways (with separate time constants) that independently govern transcription and translation (Lewandowski and Small, 2005) . We therefore examined changes in ERG1a, ERG1b, and MiRP2 expression by immunoblotting. Our results provide evidence for an effective upregulation of both ERG1 isoforms and downregulation of MiRP2 in basal VSNs. However, given that stimulation was based on chemically complex sources of social cues (both volatile and nonvolatile), it appears likely that further expression changes, beyond the scope of this study, could have occurred in both basal and apical neurons.
A key issue in interpreting our data are to resolve whether regulated gene expression is reflected in VSN physiology. We find significantly reduced ERG currents in VSNs from stimulusdeprived mice, accompanied by defects in adequate AP output in response to medium-to-high stimulation levels. Together, the combination of microarray profiling, immunoblotting, and patch-clamp recordings supports the concept that, by increasing ERG expression (and potentially MiRP2 downregulation) during periods of increased pheromonal stimulation, basal VSNs extend their dynamic firing range to (re)establish a meaningful sensory output.
